United States Dispensing Rate Maps

The data in the maps show the geographic distribution in the United States of retail pharmacy dispensed opioid,1 buprenorphine, and naloxone prescriptions per 100 persons per year from 2019–2022. 2,3

Table 1. Total Number and Rate of Opioid, Buprenorphine, and Naloxone Prescriptions Dispensed, United States, 2019-2022

1 Opioid prescriptions, including buprenorphine formulations commonly prescribed for treating pain (Belbuca and Butrans), codeine, fentanyl, hydrocodone, hydromorphone, methadone, morphine, oxycodone,  oxymorphone, propoxyphene, tapentadol, and tramadol, were identified using National Drug Codes.

2 Source for all dispensing data: IQVIA Xponent 2019–2022. IQVIA Xponent is based on a sample of approximately 56,500 retail (non-hospital) pharmacies, which dispense nearly 93% of all retail prescriptions in the United States. For this database, a prescription is a new or refilled prescription dispensed at a retail pharmacy in the sample and paid for by commercial insurance, Medicaid, Medicare, cash or its equivalent, and other third-party coverage. This database does not include mail-order prescriptions. Geographic location is based on the location of the prescriber. Methadone dispensed through methadone treatment programs is not included in the IQVIA Xponent data.

3 For the calculation of dispensing rates, numerators are the projected total number of prescriptions dispensed annually at the state, county, or national level. Annual resident population denominators were obtained from the U.S. Census Bureau.

Data updated October 2023, rates are subject to change with future data updates.

Access the latest guideline, data, and resources